Cubist Pharma Initiated at Neutral and 2 Initiated Shares on the Move

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage on November 9th.

Ironwood Pharma (NASDAQ:IRWD): Mizuho initiated coverage of this company with a rating of Buy and a price target of $22.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

Forest Labs (NYSE:FRX): Mizuho initiated coverage of this company with a rating of Buy and a price target of $45.

Cubist Pharma (NASDAQ:CBST): Mizuho initiated coverage of this company with a rating of Neutral and a price target of $44.

Don’t Miss: Can Best Buy Hold On to Its Value?


More Articles About:   , , , , , ,  

More from The Cheat Sheet